Evernorth Clinical Trial Solutions
Connecting patients to care through clinical research
Empower your members to contribute to the future of care
Connecting individuals to participate in clinical research doesn't just help overcome barriers - such as lack of approved therapy options or difficulty accessing the latest treatments due to cost or geographic location. It can also help advance efforts to develop clinical breakthroughs for others with their diagnosis. This expands the possibilities of better care and outcomes across your population.
The need for more inclusive clinical research:
43.2%
higher mortality rate of stomach cancer for those living in persistent poverty1
20%
higher mortality rate for rural vs. urban populations2
78%
of participants in clinical research studies are white,3 despite making up just 64% of the U.S. population4
Improving equitable access to research opportunities
By saying “yes” to promoting inclusive clinical research through Evernorth Clinical Trial Solutions, plan sponsors can:
Access
Ensure all populations have access to the most cutting-edge treatments for their condition, which may not be available through standard care.
Efficient
Enable accurate and efficient recruitment for relevant research opportunities, accelerating the process of connecting members to the appropriate care for their diagnosis.
Effective
Help reduce disease burden, increase safety and improve cost management of complex conditions with the most effective treatments available.
Sources
- American Association for Cancer Research (ACCR), “Cancer Disparities Progress Report.” 2022.
- Centers for Disease Control and Prevention (CDC), “Trends in Death Rates in Urban and Rual Areas: United States, 1999-2019.” 2021.
- U.S. Food and Drug Administration (FDA), “2015-2019 Drug Trials Snapshots Summary Report.” 2020.
- U.S. Census Bureau, “Measuring Racial and Ethnic Diversity for the 2020 Census.” 2021.